Want to join the conversation?
$PRGO's Rx Pharmaceuticals segment posted 34% net sales growth due to increase in existing product sales & strong new product launches. Adjusted margins were unchanged due to continued investments in R&D and in its specialty pharma sales force. Specialty Sciences net sales were $85MM in 3Q15 and were essentially flat on a constant currency basis.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.